Accelerate Your Clinical Trial Program with MLM’s Advanced Immunoassay Capabilities

At MLM, we deliver high-performance, fully customizable immunoassay solutions designed to meet the complex demands of modern preclinical and clinical trials. As a global specialty and central laboratory partner, we combine scientific expertise, advanced technologies, and robust infrastructure across our laboratories in Germany and the United States to generate reliable, high-quality data that drives smarter decisions and faster development timelines.

The MLM Advantage

Biomarker Expertise that Drives Precision
Our scientists specialize in biomarker discovery and validation, supporting predictive and prognostic strategies essential for patient stratification and companion diagnostics.

Tailored Assay Development
No two studies are the same. We collaborate closely with your team to design and validate immunoassays aligned with your drug targets, therapeutic area, and study endpoints.

High-Quality Data with Rapid Turnaround
From sample handling to final reporting, our rigorous quality systems ensure reproducible, high-integrity data—delivered quickly to keep your program moving forward.

Comprehensive Immunogenicity & Safety Testing
We provide end-to-end immunogenicity assessment, including anti-drug antibody (ADA) detection and cytokine release assays, helping you fully understand immune responses to your therapy.

Advanced PK/PD Insights
Our platforms enable precise quantification of drug levels and biomarker dynamics, generating critical pharmacokinetic and pharmacodynamic insights.

Regulatory-Ready Compliance
All assays are developed and validated in accordance with global regulatory standards (GLP, GCP). We support your regulatory submissions with complete, audit-ready documentation.

Comprehensive Immunoassay Technologies

MLM offers a broad and flexible immunoassay platform to support every stage of drug development:

• ELISA – Reliable, high-throughput quantification of proteins, hormones, and antibodies

• CLIA – Enhanced sensitivity for low-abundance biomarkers

• RIA – Highly specific detection of small molecules and peptides

• ECLIA – Robust, wide dynamic range for PK/PD and immunogenicity studies

• TRACE – Ultra-sensitive detection for challenging analytes

• Turbidimetry & Nephelometry – Fast, reliable protein and antibody quantification

• Western Blot & Immunoprecipitation – Protein characterization and biomarker validation

• Flow Cytometry (FIA) – Multiparametric immune profiling and cell-based assays

Built for Complex Global Trials

As a right-sized global partner, MLM combines the scalability of a central lab with the flexibility and responsiveness of a specialty provider. Our integrated infrastructure supports programs from preclinical through Phase IV, backed by:

• Harmonized global operations and logistics

• Advanced sample management and traceability systems

• Real-time data access through secure digital platforms

• An expanding assay menu with 1,500+ parameters and custom development capabilities

Partner with Confidence

Choosing the right laboratory partner can define the success of your clinical program. With deep scientific expertise, comprehensive immunoassay capabilities, and a commitment to quality and responsiveness, MLM is uniquely positioned to support your journey from discovery to market.

Let’s work together to accelerate innovation and improve patient outcomes worldwide.

Looking for specific assays? Explore our assay menu or connect with our team to discuss your study needs.